ArteraAI is happy to announce that the #ArteraAI Prostate Test is the First-and-Only Predictive Test for Therapy Personalization in the 2024 National Comprehensive Cancer Network® (NCCN®) Guidelines® for Prostate Cancer. Our test is the only test included for its predictive performance, and also the first AI-enabled predictive and #prognostic test to be recommended in the guidelines for localized #prostatecancer. This is an exciting step forward for ArteraAI. As Andre Esteva, PhD, CEO and Co-Founder of ArteraAI said, “This significant milestone not only celebrates ArteraAI's success but also paves the way for the integration of AI-enabled solutions into clinical practice, illustrating their potential to enhance personalized patient care.” Read the announcement here:
ArteraAI
Hospitals and Health Care
Los Altos, California 4,278 followers
A leading precision medicine company, Artera develops AI-enabled tests to help personalize therapy for cancer patients.
About us
Our AI can prognosticate patient outcomes & personalize treatment in localized prostate cancer. Five Phase III randomized trials were used to develop prognostic and predictive AI biomarkers.
- Website
-
https://artera.ai
External link for ArteraAI
- Industry
- Hospitals and Health Care
- Company size
- 51-200 employees
- Headquarters
- Los Altos, California
- Type
- Privately Held
Locations
-
Primary
108 1st St
Los Altos, California 94022, US
Employees at ArteraAI
Updates
-
Get to know #ArteraAI's Wayne Lai, Senior Designer & August Employee of the Month! "Wayne brings our company vision to life through his strong impact. His innovative approach and leadership consistently deliver designs that make a difference and reflect Artera’s commitment to meaningful change." Congratulations, Waynei! 👏 We're proud to have you on our team. #personalizedcancercare #prostatecancer #AI #precisionmedicine
-
-
ICYMI: Artera's own Tim Showalter, Chief Medical Officer, was recently a part of an educational webinar, featuring current #ArteraAI Prostate Test users. Dr. Showalter was joined by guest speaker and pathologist, Adam Cole, sharing how the test works, how it can benefit patients with localized #prostatecancer, and how to start ordering the test. Learn how our multimodal AI test provides individualized results, enabling personalized treatment decision-making between clinicians and patients: https://lnkd.in/erTc8vXZ #PrecisionMedicine #CancerTreatment
-
-
At Artera, we're proud to have Dr. Tim Showalter on our team. With 20 years of medical experience, Dr. Showalter has had countless conversations with peers and patients that have refined and improved his approach to care. In a piece with Psychology Today, he shares some of these impactful discussions and how they've shaped his practice. See how these insights are helping drive our commitment to personalized and exceptional #patientcare: https://bit.ly/3WogLZh #personalizedcancercare #prostatecancer #AI #precisionmedicine
What My Patients Have Taught Me During Their Cancer Journeys
psychologytoday.com
-
We're proud to announce that we're officially #capaccredited! CAP Accreditation is globally recognized as a sign of a laboratory's high quality standards. Inspectors rigorously examined our records, processes, staff, equipment, safety programs, and overall management to verify that it meets #bestpractices.
-
-
Congratulations to our very own Trevor Royce MD MPH FASCO and the rest of the 2024 #FASCO recipients! We know this is a huge accomplishment and we're excited to be working with you all to continue advancing medicine and cancer care. https://heyor.ca/Mw3xQ0
-
artera.ai/for-patients is your resource for navigating #cancertreatment with confidence. Discover how the #ArteraAI Prostate Test can help mitigate uncertainty around treatment choices, by providing personalized results for shared decision-making through the use of #AI, and helping physicians determine if treatment intensification is needed. Cancer is personal. Cancer therapy should be, too.
Artera | For Patients
https://artera.ai
-
With all the talk of #artificialintelligence these days, it's sometimes hard to really understand what the future holds. That's why it's even more important to go back to #firstprinciples and understand what problems #AI is meant to solve. Here from our own CEO, Andre Esteva, PhD, and his thoughts about why #precisionmedicine, with all its appeal and benefits, has struggled to scale and how #ArteraAI is a potential path forward. https://lnkd.in/eMHt5r9d
Unlocking the Global Potential of Precision Medicine with AI
medium.com
-
Happy #NationalInternDay! Today, we celebrate the incredible contributions of our talented interns who are at the forefront of revolutionizing personalized #cancertreatment. Your hard work, enthusiasm, and commitment make a difference in the lives of cancer patients. Together, we're shaping the future of #medicalAI and personalized treatment. 🤝 #PrecisionMedicine #InternDay
-
-
ICYMI: UroToday + GU OncToday hosted a multi-disciplinary panel discussion on the impact of AI on prostate cancer risk stratification. Dr. Dan Spratt, a radiation oncologist from University Hospitals, shared his thoughts on the #ArteraAI Prostate Test and how it's changing treatment decisions. Hear more insights from Dr. Zachary Klaassen, Dr. Neal Shore, and Dr. Alicia Morgans in the full interview: [https://bit.ly/3VZHvhi].